Facebook tracking pixel

Coming Soon

S10.AI's Next-Generation Telehealth Platform

N15.1
ICD-10-CM
Emphysematous Pyelonephritis

Emphysematous pyelonephritis (EPN) diagnosis, treatment, and clinical documentation guidelines. Learn about gas-forming pyelonephritis symptoms, ICD-10 codes, medical coding best practices, and healthcare resources for EPN. Find information on EPN diagnosis criteria, radiological findings, and patient management strategies. This resource supports accurate clinical documentation and coding for emphysematous pyelonephritis.

Also known as

EPN
Gas-forming pyelonephritis

Diagnosis Snapshot

Key Facts
  • Definition : Severe kidney infection with gas formation within the kidney tissue.
  • Clinical Signs : Fever, flank pain, nausea, vomiting, confusion, and possibly sepsis.
  • Common Settings : Diabetes, urinary tract obstruction, immunocompromised individuals.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC N15.1 Coding
N75.0

Acute pyelonephritis

Kidney infection with sudden onset.

N75.9

Pyelonephritis, unspecified

Kidney infection without specific details.

A49.0

Staphylococcal infection of kidney

Kidney infection caused by staphylococcus bacteria.

A49.9

Bacterial infection of kidney, unspecified

Kidney infection caused by unspecified bacteria.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the diagnosis Emphysematous Pyelonephritis?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Severe kidney infection with gas
Kidney infection without gas
Kidney abscess, localized infection

Documentation Best Practices

Documentation Checklist
  • Document gas in renal parenchyma/collecting system.
  • Confirm diagnosis with CT/ultrasound imaging.
  • Specify severity (eg, Type I/II EPN).
  • Document patient's diabetic status.
  • Note symptoms: fever, flank pain, nausea/vomiting.

Coding and Audit Risks

Common Risks
  • Sepsis Miscoding

    Confusing EPN with urosepsis can lead to incorrect sepsis severity coding and inaccurate DRG assignment.

  • Diabetes Co-coding

    Failing to capture diabetes as a comorbidity in EPN patients impacts risk adjustment and reimbursement.

  • Specificity Documentation

    Lack of specific documentation differentiating EPN from other infections can cause coding errors and claim denials.

Mitigation Tips

Best Practices
  • Early diagnosis via CT scan for accurate ICD-10 coding (N10, N12)
  • Document gas presence, severity for CDI, risk adjustment (HCCs)
  • Prompt antibiotic treatment, source control (nephrostomy) for sepsis prevention
  • Blood cultures, urine analysis for targeted therapy, compliance monitoring
  • Diabetes management crucial for preventing recurrence, optimizing outcomes

Clinical Decision Support

Checklist
  • Confirm diabetes or immunocompromise documented.
  • Verify acute pyelonephritis signs/symptoms.
  • Check imaging for gas within renal parenchyma.
  • Review urinalysis for infection evidence.
  • Ensure blood cultures ordered and documented.

Reimbursement and Quality Metrics

Impact Summary
  • Emphysematous Pyelonephritis (EPN) reimbursement hinges on accurate ICD-10 coding (N10, N11.8, etc.) and thorough documentation of infection severity, gas presence, and complications.
  • Coding EPN with sepsis or acute kidney injury impacts MS-DRG assignment and potential reimbursement. Specificity is crucial for appropriate payment.
  • Quality metrics for EPN involve tracking sepsis management bundles, time to antibiotics, and acute kidney injury prevention strategies.
  • Accurate EPN coding improves hospital data reporting for infection control, epidemiological studies, and resource allocation.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the key differentiating factors in the diagnosis of emphysematous pyelonephritis (EPN) versus other complicated urinary tract infections?

A: Emphysematous pyelonephritis (EPN), unlike typical or even other complicated urinary tract infections (UTIs), is characterized by the presence of gas within the renal parenchyma, collecting system, or perirenal tissues. This gas formation, typically from bacterial fermentation producing carbon dioxide and hydrogen, is a crucial distinguishing feature. While other complicated UTIs may involve renal dysfunction or obstruction, they do not exhibit gas on imaging. Clinically, EPN often presents with more severe systemic symptoms like sepsis, including high fever, chills, and flank pain, compared to uncomplicated UTIs. Furthermore, EPN tends to occur in patients with underlying risk factors, particularly uncontrolled diabetes. Distinguishing EPN requires imaging studies, typically CT scans, which are more sensitive than ultrasound for gas detection. Accurate and rapid diagnosis of EPN is critical due to its higher risk of morbidity and mortality compared to other UTIs. Explore how risk stratification can inform your EPN management approach.

Q: How does the management of emphysematous pyelonephritis (EPN) differ in patients with uncontrolled diabetes compared to non-diabetic individuals?

A: Managing emphysematous pyelonephritis (EPN) in patients with uncontrolled diabetes presents unique challenges. Diabetic patients, especially those with poor glycemic control, are significantly more susceptible to developing EPN and experience more severe complications. This is due to factors like impaired immune function, microvascular disease, and increased susceptibility to infections. Aggressive blood glucose control is paramount in these patients alongside standard EPN treatment. Management typically involves broad-spectrum antibiotics targeting common causative organisms like E. coli and Klebsiella pneumoniae, along with urgent drainage of the infected kidney. The choice between percutaneous drainage and nephrectomy is often influenced by the extent of tissue necrosis and the patient's overall condition. Diabetic patients may require closer monitoring for complications like sepsis and acute kidney injury. Consider implementing a multidisciplinary approach involving nephrologists, endocrinologists, and interventional radiologists to optimize patient outcomes in this complex clinical scenario. Learn more about the role of early glycemic control in EPN management.

Quick Tips

Practical Coding Tips
  • Code N15.1 for EPN
  • Document gas/abscess
  • Query physician for acuity
  • Consider laterality codes
  • Check for sepsis/shock

Documentation Templates

Patient presents with symptoms suggestive of emphysematous pyelonephritis (EPN), also known as gas-forming pyelonephritis.  Clinical presentation includes fever, flank pain, nausea, vomiting, and potentially septic shock.  Urinalysis reveals pyuria, bacteriuria, and possible hematuria.  Imaging studies, such as CT scan or ultrasound of the kidneys, ureters, and bladder (KUB), demonstrate gas within the renal parenchyma, collecting system, or perinephric space, confirming the diagnosis of EPN.  Differential diagnosis includes renal abscess, infected renal cyst, and other gas-producing infections.  Patient's medical history includes poorly controlled diabetes mellitus, a significant risk factor for EPN.  Treatment plan includes aggressive fluid resuscitation, broad-spectrum antibiotic therapy targeting common uropathogens like Escherichia coli, and possible percutaneous drainage or nephrectomy depending on the severity and extent of gas formation.  Patient's condition will be closely monitored for response to treatment and potential complications such as renal failure or sepsis.  ICD-10 code N15.1 will be used for billing and coding purposes.  This documentation supports the medical necessity of the services rendered.